anaemias Flashcards

1
Q

True or false - you can give iron salts to patients with any type of anaemia

A

FALSE
Iron salts may be harmful if given to pt with anaemias other than those due to iron deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Iron salts should only be given to pt with anaemias due to ..

A

iron deficiency

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

what is sickle cell disease caused by

A

structural abnormality of Hb resulting in deformed, less flexible RBC

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

what is sickle cell crisis

A

infarcation of the microvasculature and restricted blood supply to organs results in severe pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

usual management of sickle cell crisis

A

usually requires hospitalisation, fluid replacement, analgesia, and treatment of any concurrent infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

complications of sickle cell crisis

A

anaemia, leg ulcers, renal failure, and increased susceptibility to infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

the following reduce the risk of infection in sickle cell disease/crisis

3x vaccine (+1), 1x penicllin

A

Pneumococcal vaccine, haemophilus influenzae type b vaccine, an annual influenza vaccine, and lifelong prophylactic penicillin reduce the risk of infection.

Hepatitis B vaccine should also be given if the patient is not immune.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is supplementation with folic acid recommended in most forms of sickle cell disease?

A

varying degrees of haemolytic anaemia are present which is accompanied by increased erythropoiesis; this may increase folate requirements and supplementation with folic acid is recommended.

optimum dose should be discussed with a specialist.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

this cytotoxic drug can prevent acute chest syndrome, reduce the freq of painful crises, and reduce transfusion requirments in sickle cell disease

A

hydroxycarbamide

(beneficial effects may not be seen for several months)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

this -zumab is an option for preventing recurrent sickle cell crises (vaso-occlusive crises)

A

Crizanlizumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

G6PD deficiency is more common in which sex?

A

males

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Which ethnicities is G6PD deficiency more common in (4)

A
  • Africa, Asia, Mediterraenean, Middle East
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Individuals with G6PD deficiency are susceptible to developing the following anaemia when they take a number of common drugs or when they have an infection

A

acute haemolytic anaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is favism

A

People with G6PD deficiency are suscepible to developing acute haemolytic anaemia when they eat fava beans (broad beans)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

People with G6PD deficiency are suscepible to developing acute haemolytic anaemia when they eat the following beans

A

fava beans (broad beans) - this is termed as favism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

When prescribing drugs for patients with G6PD deficiency, the following three points should be kept in mind:

A
  • G6PD deficiency is genetically heterogeneous; susceptibility to the haemolytic risk from drugs varies; thus, a drug found to be safe in some G6PD-deficient individuals may not be equally safe in others;
  • manufacturers do not routinely test drugs for their effects in G6PD-deficient individuals;
  • the risk and severity of haemolysis is almost always dose-related.
17
Q

T or F - the risk and severity of haemolysis in pt with G6PD deficiency is almost always dose-related.

A

true

18
Q

Drugs on UK market with definite risk of haemolysis in most G6PD-deficient individuals

A
  • Dapsone and other sulfones
  • Fluoroquinolones (including ciprofloxacin, moxifloxacin, norfloxacin, and ofloxacin)
  • Methylthioninium chloride
  • Nitrofurantoin
  • Primaquine
  • Quinolones
  • Rasburicase
  • Sulfonamides (including co-trimoxazole
19
Q

This antibiotic, commonly used for UTIs, has definite risk of haemolysis in most G6PD-deficient individuals

A

nitrofurantoin

20
Q

Very few G6PD-deficient individuals with chronic non-spherocytic haemolytic anaemia have haemolysis even in the absence of an exogenous trigger. What would happen if they were to be given drugs that have risk of haemolysis?

A

In these patients, exacerbation of haemolysis following oxidative stress, such as the administration of any of the drugs that have risk of haemolysis in pt with G6PD deficient pt, will occur.

21
Q

Drugs with possible risk of haemolysis in some G6PD-deficient individuals

A

Aspirin
Chloroquine
Menadione, water-soluble derivatives (e.g. menadiol sodium phosphate)
Quinine (may be acceptable in acute malaria)
Sulfonylureas

22
Q

This class of oral antidiabetic drugs has a possible risk of haemolysis in some G6PD deficient pt

A

SUs

23
Q

What can be used for immunosuppressive treatment for aplastic anaemia

A

Intravenous horse antithymocyte globulin in combination with ciclosporin

24
Q

What is Intravenous horse antithymocyte globulin in combination with ciclosporin used for

A

may be used as immunosuppressive treatment for aplastic anaemia.

25
Q

what is the response rate for IV horse antithymocyte globulin in combination with ciclosporin, vs ciclosporin alone for non severe aplastic anaemia

A

The response rate for non-severe aplastic anaemia is higher with this combination than with ciclosporin alone.

26
Q

This steroid is used for the prevention of adverse effects associated with antithymocyte globulin treatment (which is used for aplastic anaemia - IV horse antithymocyte globulin in combination with ciclosporin)

A

Prednisolone

27
Q

Prednisolone is used for the prevention of adverse effects associated with antithymocyte globulin treatment. Early reactions that may occur include …

A

fever, rash, fluid retention, rigors, acute respiratory distress syndrome, and anaphylaxis; serum sickness may occur 7–14 days later.

28
Q

Who can give antithymocyte globulin treatment and in which facilities

A

Antithymocyte globulin should be given under specialist supervision with appropriate resuscitation facilities

29
Q

Intravenous horse antithymocyte globulin in combination with ciclosporin, may be used as immunosuppressive treatment for aplastic anaemia.

What are some other treatment options (2)

A

ciclosporin alone or oxymetholone.

30
Q

This vitamin B is licensed for the treatment of idiopathic sideroblastic anaemia; the dose required is usually high.

A

pyridoxine HCl

31
Q

What is used to treat anaemia associated with erythropoietin deficiency in chronic renal failure and why?

A

Epoetins (recombinant human erythropoietins)
To increase the yield of autologous blood in normal individuals and to shorten the period of symptomatic anaemia in patients receiving cytotoxic chemotherapy.